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Ovarian reserve refers to the finite amount of follicles, responsible for the support of the oocytes, 
in the human ovary.  From this pool, a dominant follicle is selected to enter into the menstrual 
cycle, where the oocyte can be fertilized.  This process is dependent on the interrelationship of 10 
many hormones, such as Follicle Stimulating Hormone (FSH) and Anti-Mullerian Hormone 
(AMH).  FSH is a major component in a feedback loop that exists between hormones secreted from 
the ovaries and pituitary gland.  This inverse relationship allows the ovaries and brain to 
communicate.  AMH is produced by granulosa cells that surround the oocytes.  Abnormal levels of 
these hormones may indicate poor quality or quantity of the ovarian reserve.  Preferred methods of 15 
determining the ovarian reserve consider the patient’s chronological age, the level of Day 3 FSH, 
and the follicle count through transvaginal ultrasound.  The measurement of serum AMH levels is 
a relatively new method that is being considered for determination of the ovarian reserve, giving a 
more direct and accurate measurement.  A negative association between circulating AMH and FSH 
levels in reproductive aged women is examined.  This study illustrates AMH levels presenting the 20 
same indication of the FSH levels to the ovarian reserve.     
Introduction 
At birth, the human ovary contains a finite amount of 
primordial follicles that are responsible for the support of the 
oocytes.  This pool of available follicles is referred to as the 
ovarian reserve.  Folliculogenesis occurs when the follicles 
leave the primordial pool and develop into preovulatory 
follicles in the growing follicle pool.  From this cohort, one 
dominant follicle passes into the menstrual cycle, where the 
oocyte can be fertilized.  Follicle development is dependent 
on the interrelationship of many hormones, such as Follicle 
Stimulating Hormone (FSH) and Anti-Mullerian Hormone 
(AMH), secreted from the anterior pituitary gland and the 
ovaries, respectively (1).  Abnormal levels of these hormones 
may indicate a woman’s diminished ability or inability of 
conception.  Infertility refers to the inability of a woman to 
become pregnant after having unprotected intercourse for a 
specified amount of time, usually within a year.  
Approximately 10% of the reproductive aged female 
population, accounting for about 6.1 million women, in the 
United States is affected by infertility.  There are many 
factors that contribute to infertility, including but not limited 
to the quantity and quality of the ovarian reserve.  Couples 
struggling to become pregnant may consider fertility 
treatments, including drugs and/or surgery (2).  Since 
treatments can be financially and emotionaly draining, it is 
important to consider the patient’s ability of becoming 
pregnant based on the determination of the ovarian reserve.  
The preferred methods consider the patient’s chronological 
age, the level of Day 3 FSH, and the follicle count through 
transvaginal ultrasound.  The measurement of serum AMH 
levels is a relatively new method that is being considered for 
determination of the ovarian reserve, giving a more direct and  
accurate measurement.  The aim of this study is to 
demonstrate the association between circulating AMH and 
FSH levels in women of different reproductive ages.   
Methods Used to Determine Ovrian Reserve 
Age 
 
Recent trends show an increase in women who have started to 
plan childbearing later in life, during their 30s and 40s.  
Although studies show there is a high reduction of follicles 
after the age of 35, the diminishing rate of follicles available 
significantly varies among women of all ages.  When the 
hormones stop signaling the production of follicles and the 
ovarian reserve is completely depleted, this is knows as 
menopause, the final phase of a woman’s reproductive life 
(3).  This occurs around the average age of 51, but can occur 
earlier or even later (4).  Therefore, chronological age can be 
a misleading factor for establishing the ovarian reserve.   
 
FSH 
 
FSH is needed to protect a portion of the follicles in the 
growing follicle pool from atresia, stimulate the follicles to 
grow, and to select the highest quality follicle from its cohort 
to begin ovulation.  Low levels of FSH are found during 
follicle development, and high levels during ovulation.  The 
variation in levels of FSH is due to a feedback loop that exists 
between the hormones secreted from the ovaries and pituitary 
gland.  As antral follicles develop in the ovaries, they excrete 
Estradiol (E2) and Inhibin B.  An increase in these hormones  
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TABLE	  1	  Descriptive	  Statistics	  Column	   Size	   Range	   Max	   Min	   Mean	   Std.	  Error	   	   	  Age	   21	   11.80	   15.20	   3.40	   7.15	   0.55	   	  FSH	   21	   8.47	   8.54	   0.07	   3.06	   0.57	   	   	  AMH	   21	   15.00	   41.00	   26.00	   35.24	   0.84	   	  
 
signal the gonatropins in the pituitary gland to discontinue the 
release of FSH.  Once ovulation occurs there is a diminish in 
E2, which signals for an increase of FSH to be released.  An 
increase in FSH helps to prepare for the next cohort of 
follicles in the growing pool (5).  This inverse relationship is 
a way for the ovaries and brain to communicate.  Poor 
communication can be an indicator of poor follicle quantity 
(5,6).  The Day 3 FSH test measures serum FSH levels on the 
third day of the menstrual cycle to ensure the greatest 
accuracy possible.  However, this is an indirect measurement 
considering FSH is dependent on other hormones of the 
feedback loop.   
 
Transvaginal Ultrasound 
 
Ultrasonography used in conjunction with other tests, such as 
Day 3 FSH, may provide a more accurate reading (4).  
Transvaginal ultrasound measures the antral follicle count 
(AFC), when follicles are in an advanced stage of 
folliculogenesis (3).  This method is a subjective evaluation, 
and does not always provide an accurate follicle count (7).  It 
has not been proven that any method used in determining the 
ovarian reserve is completely reliable.  The two most widely 
used methods are the ultrasonographics and FSH, both suggest 
the AFC (4).  A method that measures the ovarian reserve 
directly would be useful. 
 
AMH 
 
A proposed test for ovarian reserve is the circulating levels of 
AMH.  AMH is produced by the granulosa cells that surround 
the oocytes in the primordial follicles and suppresses follicle 
recruitment.  As the granulosa cells enlarge, the level of AMH 
is diminished, and the follicles enter the growing pool and 
become regulated by FSH (8).  Considering AMH is directly 
involved with the primordial follicles, it is no surprise that 
studies show a significant correlation with AFC (4).  The 
measurement of AMH serum levels may be a more direct and 
accurate method of determining the ovarian reserve.   
 The aim of this study is to demonstrate the inverse 
relationship between AMH levels and, a commonly used 
method, FSH levels from a collection of blood samples in 
patients undergoing treatment for infertility.   
 
Materials and Methods 
Patients 
The study population consisted of 21 infertile patients ranging 
in ages 26-41 with normal menstrual cycles.  The blood 
samples were collected on the third day of the patient’s 
untreated cycle for AMH and FSH so an accurate comparison 
could be made regarding the hormones.  Women presenting 
with polycystic ovary syndrome (PCOS) were excluded from 
the study.   
 
Hormone Assay 
 
The patients’ blood were collected in serum seperator tubes.  
The samples were allowed to clot, centrifuged, decanted, and 
stored at -20ºC in cryotubes.  The tubes were thawed to be 
analyzed.  The serum levels were run in duplicate on a DSXTM 
Four-Plate Automated ELISA Processing System (Dynex 
Technologies; Chantilly, VA) per manufacturer’s instructions 
(Beckham Coulter, Brea, CA).  The limit of detection (LoD) 
was 0.08 ng/mL with a 95% probability and the limit of 
quantitation (LoQ) is 0.16 ng/mL at a total imprecision of 
20%.   
 
Statistical Analysis 
 
The initial FSH tests were conducted to determine the 
outcome of hormonal treatments of IVF patients. The 
student’s test was performed to examine relationships between 
FSH, AMH, and chronological age.   
 Statistical calculations were performed with SigmaPlot for 
Windows, version 11.00 (Jandel Scientific Corportation, San 
Rafael, CA) and MedCalc, version 11.4.20 (MedCalc 
Software, Belgium).  Linear regression analysis was used to 
investigate the relationships between the measures of the 
study.  All the linear regression graphs had 95% confidence 
intervals. 
 A receiver operator curve (ROC) used the mean levels of 
FSH to consider probable ranges of AMH that can be used for 
analysis.     
  
Results 
A statistical summary for each of the parameters considered in 
the study are illustrated in Table 1.   
 In Figure 1, a relationship between FSH and chronological 
age is demonstrated.  There is a significant 33% increase in 
FSH levels from the the <30 age group to the 31-36 age 
group.  Another 26% increase occurs at the age group >36.  
FSH levels increased at predictable rates with the increase of 
age. 
   A correlation is not found between AMH levels and 
chronological age due to the relatively low sample size.  AMH 
levels decreased by 40% from the range of women classified 
in the range of <30 to the range of 31-36 years.  The levels 
decreased only by 4% for the women >36 years.  The results 
are illustrated in Figure 2.  
 The regression analysis is used to show any linear 
correlation.  Figure 3 shows a correlation between serum 
AMH and FSH levels.   
 The ROC determined 0.88 as the AMH cut off for the range 
of levels.   The range was rounded up to include the ranges of  
above one (>1) and below one (<1), as illustrated in Table 2.   
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 TABLE	  2	  Receiver	  Operator	  Curve	  Results	  Group	   Size	   FSH	  Mean	   SEM	  <1	  AMH	   6	   9.53	   1.29	  >1	  AMH	   15	   6.20	   0.38	  
 
Discussion 
The results for the levels of FSH corresponding with age are 
as expected.  Age affects the quality of antral follicles, and 
therefore the FSH levels show the decrease in quality (10).  It 
has been found that even when FSH is measured on the third 
day of the cycle, the levels can vary significantly from month 
to month (3).  In these types of cases it would be difficult to 
indicate a normal level of FSH for the patient, and the results 
may be misleading.  During menopause, the antral follicle 
count (AFC) is not sufficient enough to produce enough 
Inhibin B to reduce the level of FSH.  The high level of FSH 
can not be seen until the patient has reached menopause (12).  
Therefore, FSH may be used as an indicator of the ovarian 
reserve, but the response to the feedback loop is prolonged 
and does not reveal the future ovarian reserve lifespan.  
Although AMH and FSH are not directly dependent on each 
other, there is an inverse correlation.  When these hormones 
are measured and used as indicators for fertility treatment 
outcomes, AMH predicts a greater percentage of successful 
pregnancies when AFC is considered (8).  Considering the 
faults that are found in Day 3 FSH testing, and the correlation 
that is found between AMH and FSH, it only makes sense to 
use the more direct and reliable measurement of the two 
hormones.   
 Although a decrease in AMH levels are seen in older 
women, it is seen in women throughout all of the age ranges.  
AMH is directly related to the ovarian reserve because it is 
secreted from the follicles in the primordial pool.  The ovarian 
reserve that a female is born with and the degree of decline of 
the primordial follicle pool throughout the lifespan varies 
significantly among every female.  Yet, throughout the cycle, 
AMH levels remain consistent (7).  This makes AMH a more 
reliable test that is not constrained to a time frame that it must 
be measured during the menstrual cycle.  AMH is a direct 
measurement to the primoridal follicles that are available and 
show a decrease in the available pool before any other 
method, providing a huge advantage.  This diagnostic test can 
detect a decrease in AMH levels five years before a difference 
in the levels of FSH or Inhibin B are noticed (11).  There is a 
correlation between AMH levels and the duration of prior 
menstrual cycles.  One of the first signs of approaching 
menopause is the shortening of menstrual cycles.  AMH 
shows a correlation with the (8).  Better understanding of a 
patient’s ovarian reserve would allow for physicians to create 
a better treatment plan for their patient.  Therefore, AMH may 
be used in conjunction with ultrasonography to ensure the best 
possible indication of the ovarian reserve. 
 Compared with the indirect measurement of FSH, AMH 
also has a higher positive correlation of the oocyte count 
investigated in a study of IVF patients (7). Many factors, such 
as age, play a role in a pregnancy’s success that can effect the 
quantity and quality of the oocytes found in the follicles.  
There is a correlation found between the quality of the oocytes 
retrieved from an ovary after hyperstimlation (9).  It is 
undecided if the levels of AMH are an indicator of the 
quantity of the follicles or the quality in terms of the follicle 
maturity (10).  In any case, the measurement is significant. 
 Every lab has a different scale that considers a FSH cut off 
value normal for indication of a successful pregancy.  It is 
generally excepted that FSH under 10 mIU/mL (<10) is 
normal and above 10 mIU/mL (>10) is abnormal for a female 
during her reproductive years (7).  It is critically important to 
set a range for AMH levels as well when determining the 
outcome for infertility patients.  The ROC suggests 0.88 
ng/ml as a cut off value for AMH levels determining 
normality.  Rounded >1 ng/mL in AMH levels corresponds 
with the normal range for FSH levels, and <1 ng/ml in AMH 
levels with the abnormal range for FSH levels.  This value is 
in the same range compared to other findings of the cut off 
value as 0.99 ng/ml and 1.05 ng/ml (9).     
 The first step in AMH being accepted as the most reliable 
indicator of ovarian reserve, and of infertility outcome is to 
prove that AMH is at least as good of an indicator as the 
commonly used tested FSH levels.  This study shows the 
predicted and intended correlation. 
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